Richard Friedrich Radlberger

Richard Friedrich Radlberger, MD is a researcher in the Department of Neurology at Paracelsus Medical University. His work spans multiple neurological subspecialties with particular focus on complex neurological disorders and their management.

Dr. Radlberger's research interests include cerebral amyloid angiopathy, multiple sclerosis, trigeminal neuralgia, and neurosurgical complications. His work examines the intersection of neurology and immunology, particularly regarding vaccine responses in neurological patients and long-term outcomes of neurosurgical interventions. He has made significant contributions to understanding iatrogenic neurological disorders and novel therapeutic approaches for pain management.

His publication record shows consistent research activity from 2020 through 2025, with increasing output in recent years. The research spans case reports, original articles, and studies examining neurological complications and therapeutic interventions. His work demonstrates expertise across both clinical neurology and translational research areas.

Notable research areas include:

• Cerebral amyloid angiopathy related to dura mater transplants
• Multiple sclerosis diagnosis and treatment monitoring
• Novel applications of botulinum toxin in neurorehabilitation
• Neurological complications of immunomodulatory therapies

Dr. Radlberger frequently collaborates with colleagues across neurology and neurosurgery, contributing to multidisciplinary research efforts. His work has appeared in journals including CUREUS JOURNAL OF MEDICAL SCIENCE, FRONTIERS IN IMMUNOLOGY, and EUROPEAN JOURNAL OF NEUROLOGY.